CN102391088B - (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber and preparation method thereof - Google Patents
(1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber and preparation method thereof Download PDFInfo
- Publication number
- CN102391088B CN102391088B CN201110261873.4A CN201110261873A CN102391088B CN 102391088 B CN102391088 B CN 102391088B CN 201110261873 A CN201110261873 A CN 201110261873A CN 102391088 B CN102391088 B CN 102391088B
- Authority
- CN
- China
- Prior art keywords
- nopinone
- ultraviolet
- arylmethylene
- ultraviolet absorber
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- XZFDKWMYCUEKSS-UHFFFAOYSA-N (+)-6,6-Dimethylbicyclo[3.1.1]heptan-2-one Natural products C1C2C(C)(C)C1CCC2=O XZFDKWMYCUEKSS-UHFFFAOYSA-N 0.000 title claims abstract description 110
- 239000006097 ultraviolet radiation absorber Substances 0.000 title abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 10
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 claims abstract description 6
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 claims abstract description 5
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 claims abstract description 5
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930006722 beta-pinene Natural products 0.000 claims abstract description 5
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000005882 aldol condensation reaction Methods 0.000 claims abstract description 4
- 150000003934 aromatic aldehydes Chemical class 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 2
- 238000005815 base catalysis Methods 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims 4
- 239000002250 absorbent Substances 0.000 claims 4
- 239000012286 potassium permanganate Substances 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 27
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 abstract description 8
- 241000723346 Cinnamomum camphora Species 0.000 abstract description 5
- 229930008380 camphor Natural products 0.000 abstract description 5
- 229960000846 camphor Drugs 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 238000000862 absorption spectrum Methods 0.000 abstract description 2
- 125000002619 bicyclic group Chemical group 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- 238000002835 absorbance Methods 0.000 description 18
- 239000006096 absorbing agent Substances 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- 238000010992 reflux Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- -1 terpene compounds Chemical class 0.000 description 5
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- JJVNINGBHGBWJH-UHFFFAOYSA-N ortho-vanillin Chemical compound COC1=CC=CC(C=O)=C1O JJVNINGBHGBWJH-UHFFFAOYSA-N 0.000 description 4
- 238000001782 photodegradation Methods 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 235000007586 terpenes Nutrition 0.000 description 3
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- AJQLCJDIVPDCGZ-UHFFFAOYSA-N potassium 2-methylpropan-2-olate toluene Chemical compound CC1=CC=CC=C1.CC(C)([O-])C.[K+] AJQLCJDIVPDCGZ-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- UKWCVKJHOSEORN-UHFFFAOYSA-N 3-benzylidene-4-tert-butyl-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one Chemical class CC1(C)C2(C(C)(C)C)CCC1(C)C(=O)C2=CC1=CC=CC=C1 UKWCVKJHOSEORN-UHFFFAOYSA-N 0.000 description 1
- RXXCIBALSKQCAE-UHFFFAOYSA-N 3-methylbutoxymethylbenzene Chemical compound CC(C)CCOCC1=CC=CC=C1 RXXCIBALSKQCAE-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-JLHYYAGUSA-N 4-[(e)-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C\C1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-JLHYYAGUSA-N 0.000 description 1
- QKNXZMNWGNBKIA-UHFFFAOYSA-N C(C)(C)(C)O.C[O-].[Na+] Chemical compound C(C)(C)(C)O.C[O-].[Na+] QKNXZMNWGNBKIA-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 230000037338 UVA radiation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001555 benzenes Chemical group 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100001183 nonphototoxic Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- MCNTVFNKNAAKPJ-UHFFFAOYSA-N potassium;2-methylpropan-2-ol;2-methylpropan-2-olate Chemical compound [K+].CC(C)(C)O.CC(C)(C)[O-] MCNTVFNKNAAKPJ-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003870 salicylic acids Chemical class 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- OVYTZAASVAZITK-UHFFFAOYSA-M sodium;ethanol;hydroxide Chemical compound [OH-].[Na+].CCO OVYTZAASVAZITK-UHFFFAOYSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229940085790 synthetic camphor Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- ZBZJXHCVGLJWFG-UHFFFAOYSA-N trichloromethyl(.) Chemical compound Cl[C](Cl)Cl ZBZJXHCVGLJWFG-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
本发明公开了一种(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂及其制备方法,该紫外线吸收剂为(1R,5R)-(-)-3-(4′-羟基亚苄基)诺蒎酮、(1R,5R)-(-)-3-(4′-羟基-3′-甲氧基亚苄基)诺蒎酮、(1R,5R)-(-)-3-(2′-羟基-3′-甲氧基亚苄基)诺蒎酮、(1R,5R)-(-)-3-(4′-氯亚苄基)诺蒎酮或(1R,5R)-(-)-3-(呋喃-2′-基亚甲基)诺蒎酮。本发明以廉价易得的β-蒎烯为原料,经选择性氧化制得具有与樟脑相似的双环结构的诺蒎酮,再与不同结构的芳香醛进行羟醛缩合反应,合成紫外线吸收剂。具有合成路线简单、操作简便经济、得率高、污染少等优点,克服了樟脑合成路线长、价格高等不足。所合成的紫外线吸收剂具有紫外吸收效果好、紫外吸收光谱范围广以及稳定性好等优点,在吸收紫外线中能具有很好的应用前景。
The invention discloses a (1R,5R)-(-)-3-arylmethylene nopinone ultraviolet absorber and a preparation method thereof. The ultraviolet absorber is (1R,5R)-(-)-3 -(4′-Hydroxybenzylidene)nopinone, (1R,5R)-(-)-3-(4′-hydroxy-3′-methoxybenzylidene)nopinone, (1R,5R )-(-)-3-(2′-Hydroxy-3′-methoxybenzylidene)nopinone, (1R,5R)-(-)-3-(4′-chlorobenzylidene)nopine Pinone or (1R,5R)-(-)-3-(furan-2'-ylmethylene)nopinone. The invention uses cheap and easy-to-obtain β-pinene as a raw material, prepares nopinone with a bicyclic structure similar to camphor through selective oxidation, and then performs aldol condensation reaction with aromatic aldehydes of different structures to synthesize an ultraviolet absorber. The method has the advantages of simple synthetic route, convenient and economical operation, high yield, less pollution, etc., and overcomes the disadvantages of long synthetic route and high price of camphor. The synthesized ultraviolet absorber has the advantages of good ultraviolet absorption effect, wide ultraviolet absorption spectrum range and good stability, and has a good application prospect in absorbing ultraviolet rays.
Description
技术领域 technical field
本发明涉及紫外线吸收剂及其制备方法,具体涉及一种(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂及其制备方法。The invention relates to an ultraviolet absorber and a preparation method thereof, in particular to a (1R,5R)-(-)-3-arylene nopinone ultraviolet absorber and a preparation method thereof.
背景技术 Background technique
紫外线辐射量随着臭氧层的破坏不断增加,给人类带来的影响已被世界范围所认识。皮肤科学界将太阳光中所含紫外线分为200~280nm的短波紫外线(UVC)、280~320nm的中波长紫外线(UVB)和320~400nm的长波紫外线(UVA),其中280nm以下的紫外线被臭氧层吸收而不能到达地面。到达地面的紫外线会给人们的皮肤带来各种影响,UVB能引起皮肤产生红斑或水疱,促进黑色素形成,使皮肤产生色素沉着,致使褐斑的形成,是主要的防范对象。以前曾认为UVA对皮肤不会产生大的影响,但通过电子显微镜或组织化学的方法均已证明接受过量的UVA照射会给皮肤带来一定的影响,UVA段紫外光与UVB不同,其能量可以达到皮肤真皮层,给血管壁或结合组织中的弹性纤维带来缓慢的变化,从而引起皮肤的褐色化、皮肤弹性下降,促进皱纹的发生,使人急剧老化,另外还能促进红斑反应甚至引发光毒性或光敏反应。敏感皮肤在日光下连续经过UVB和UVA的辐射还能损伤DNA使免疫力下降,甚至诱发皮肤癌。所以防御过量的UVA、UVB照射保护人体免受伤害、延缓衰老显得尤为重要。化妆品用理想紫外线吸收剂应具备如下性质:能够吸收280~360nm的紫外光;消光系数高,用量少;不受化妆品中溶剂的影响;水溶性小;无毒无光毒性;不和皮肤及化妆品组分起反应,且相溶性好;不引起皮肤干燥,无异味,价格低廉等特点。The amount of ultraviolet radiation has been increasing with the destruction of the ozone layer, and its impact on human beings has been recognized worldwide. The skin science community divides the ultraviolet rays contained in sunlight into short-wave ultraviolet rays (UVC) of 200-280nm, medium-wavelength ultraviolet rays (UVB) of 280-320nm and long-wave ultraviolet rays (UVA) of 320-400nm. Among them, ultraviolet rays below 280nm are destroyed by the ozone layer. Absorbed and cannot reach the ground. The ultraviolet rays that reach the ground will have various effects on people's skin. UVB can cause erythema or blisters on the skin, promote the formation of melanin, cause skin pigmentation, and lead to the formation of brown spots. It is the main prevention object. It was previously thought that UVA would not have a great impact on the skin, but it has been proved by electron microscopy or histochemical methods that excessive UVA irradiation will have a certain impact on the skin. UVA segment ultraviolet light is different from UVB, and its energy can be Reaching the dermis layer of the skin, it brings slow changes to the elastic fibers in the blood vessel wall or combined tissue, which causes the browning of the skin, the decrease of skin elasticity, promotes the occurrence of wrinkles, and makes people age rapidly. In addition, it can also promote erythema reaction and even trigger Phototoxicity or photosensitivity reactions. Continuous UVB and UVA radiation on sensitive skin can damage DNA, reduce immunity, and even induce skin cancer. Therefore, it is particularly important to defend against excessive UVA and UVB radiation to protect the human body from damage and delay aging. An ideal UV absorber for cosmetics should have the following properties: able to absorb ultraviolet light from 280 to 360 nm; high extinction coefficient and low dosage; not affected by solvents in cosmetics; low water solubility; non-toxic and non-phototoxic; not compatible with skin and Cosmetic components react, and have good compatibility; do not cause skin dryness, no peculiar smell, low price and so on.
可用于化妆品的紫外线吸收剂有60多种,但出于安全性的考虑,各国对紫外线吸收剂的使用均有严格的限定。其中,美国FDA于1993年批准可使用的紫外线吸收剂有16种,欧盟于2000年批准允许使用的有24种,日本2001年允许使用的有27种。我国2007年《化妆品卫生规范》中规定,化妆品组中可用的化学防晒剂包括樟脑类、桂皮酸酯类、水杨酸类、苯甲酸类、苯酮类、三嗪类、苯唑类等。There are more than 60 kinds of ultraviolet absorbers that can be used in cosmetics, but for safety reasons, countries have strict restrictions on the use of ultraviolet absorbers. Among them, there are 16 kinds of ultraviolet absorbers approved by the US FDA in 1993, 24 kinds approved by the European Union in 2000, and 27 kinds allowed by Japan in 2001. my country's 2007 "Hygienic Standards for Cosmetics" stipulates that chemical sunscreens that can be used in cosmetics include camphor, cinnamic acid esters, salicylic acids, benzoic acids, benzophenones, triazines, benzos, etc.
目前用作紫外线吸收剂的萜烯类化合物主要是樟脑衍生物,包括3-亚苄基樟脑、4-甲基苄亚基樟脑、亚苄基樟脑磺酸、对苯二亚甲基二樟脑磺酸等衍生物。(叔丁基)亚苄基樟脑衍生物不仅可作为紫外线吸收剂,同时也可作抗氧剂和药物用于治疗皮肤过敏、消炎等,而对苯二亚甲基二樟脑磺酸是一种广谱紫外线吸收剂,吸光范围在290~390nm之间,且在345nm处具有最高的吸收峰。合成樟脑作为萜烯类化合物,其合成过程存在合成路线长、环境污染大等缺点,而天然樟脑则存在价格高、来源少等不足之处。为此,开发新型的萜烯类紫外线吸收剂尤显紧迫。The terpene compounds currently used as UV absorbers are mainly camphor derivatives, including 3-benzylidene camphor, 4-methylbenzylidene camphor, benzylidene camphorsulfonic acid, terephthalylidene dicamphorsulfonic acid acid derivatives. (tert-butyl)benzylidene camphor derivatives can not only be used as ultraviolet absorbers, but also can be used as antioxidants and medicines for the treatment of skin allergies, anti-inflammatory, etc., and terephthalic acid is a kind of Broad-spectrum ultraviolet absorber, the absorption range is between 290-390nm, and has the highest absorption peak at 345nm. Synthetic camphor, as a terpene compound, has disadvantages such as long synthetic route and large environmental pollution in its synthesis process, while natural camphor has disadvantages such as high price and few sources. For this reason, it is particularly urgent to develop novel terpene UV absorbers.
发明内容 Contents of the invention
发明目的:针对现有技术中存在的不足,本发明的目的是提供一种(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂,使其具有吸收紫外线谱广、稳定性强、制备简单等优点。本发明的另一目的是提供一种制备上述一种(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂的方法。Purpose of the invention: for the deficiencies in the prior art, the purpose of the present invention is to provide a kind of (1R, 5R)-(-)-3-aryl methylene nopine ketone ultraviolet absorber, which has the absorption ultraviolet spectrum Wide range, strong stability, simple preparation and other advantages. Another object of the present invention is to provide a method for preparing the above-mentioned (1R,5R)-(-)-3-arylmethylene nopinone UV absorber.
技术方案:为了实现上述发明目的,本发明采用的技术方案为:Technical solution: In order to realize the above-mentioned purpose of the invention, the technical solution adopted in the present invention is:
(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂,结构通式为:(1R, 5R)-(-)-3-arylmethylene nopinone UV absorber, the general structural formula is:
式中,Ar为或或或或(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂,具体结构和名称如下:In the formula, Ar is or or or or (1R, 5R)-(-)-3-Arylidene nopinone UV absorber, the specific structure and name are as follows:
(1R,5R)-(-)-3-(4′-羟基亚苄基)诺蒎酮,(1); (1R,5R)-(-)-3-(4'-hydroxybenzylidene)nopinone, (1);
(1R,5R)-(-)-3-(4′-羟基-3′-甲氧基亚苄基)诺蒎酮,(2); (1R,5R)-(-)-3-(4'-hydroxy-3'-methoxybenzylidene)nopinone, (2);
(1R,5R)-(-)-3-(2′-羟基-3′-甲氧基亚苄基)诺蒎酮,(3); (1R,5R)-(-)-3-(2'-hydroxy-3'-methoxybenzylidene)nopinone, (3);
(1R,5R)-(-)-3-(4′-氯亚苄基)诺蒎酮,(4); (1R,5R)-(-)-3-(4'-chlorobenzylidene)nopinone, (4);
(1R,5R)-(-)-3-(呋喃-2′-基亚甲基)诺蒎酮,(5);(1R,5R)-(-)-3-(furan-2'-ylmethylene)nopinone, (5);
一种制备(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂的方法,具体过程为:β-蒎烯经高酸性锰酸钾氧化,转化成诺蒎酮;在碱催化作用下,诺蒎酮与芳香族醛进行羟醛缩合生成系列诺蒎酮衍生物。诺蒎酮为无色油状诺蒎酮液体,得率为83.9%,纯度为95.04%,比旋光度[a]=+27.3°(c=1.0,CCl3)。A method for preparing (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorbers, the specific process is: β-pinene is oxidized by peracid potassium manganate to convert into nopinone ; Under the action of base catalysis, nopinone and aromatic aldehyde undergo aldol condensation to generate a series of nopinone derivatives. Nopinone is a colorless oily nopinone liquid with a yield of 83.9%, a purity of 95.04%, and a specific rotation [a]=+27.3° (c=1.0, CCl 3 ).
上述的(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂在吸收紫外线中的应用。The application of the above-mentioned (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber in absorbing ultraviolet rays.
上述的(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂在吸收紫外线中的应用;其中,(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂为(1R,5R)-(-)-3-(4′-羟基亚苄基)诺蒎酮、(1R,5R)-(-)-3-(4′-羟基-3′-甲氧基亚苄基)诺蒎酮、(1R,5R)-(-)-3-(2′-羟基-3′-甲氧基亚苄基)诺蒎酮、(1R,5R)-(-)-3-(4′-氯亚苄基)诺蒎酮、(1R,5R)-(-)-3-(呋喃-2′-基亚甲基)诺蒎酮或它们的混合物。The application of the above-mentioned (1R, 5R)-(-)-3-arylmethylene norpinone ultraviolet absorber in absorbing ultraviolet light; wherein, (1R, 5R)-(-)-3-arylmethylene Nopinone UV absorbers are (1R,5R)-(-)-3-(4′-hydroxybenzylidene)nopineone, (1R,5R)-(-)-3-(4′-hydroxy -3'-methoxybenzylidene)nopinone, (1R,5R)-(-)-3-(2'-hydroxy-3'-methoxybenzylidene)nopinone, (1R, 5R)-(-)-3-(4'-chlorobenzylidene)nopinone, (1R,5R)-(-)-3-(furan-2'-ylmethylene)nopinone or their mixture.
有益效果:与现有技术相比,本发明的(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂具有的突出优点是:本发明以廉价易得的β-蒎烯为原料,经选择性氧化制得具有与樟脑相似的双环结构的诺蒎酮,再与不同结构的芳香醛进行羟醛缩合反应,合成紫外线吸收剂,具有合成路线简单、操作简便经济、得率高、污染少等优点,克服了樟脑合成路线长、价格高等不足。所合成的紫外线吸收剂具有紫外吸收效果好、紫外吸收光谱范围广等优点,在吸收紫外线中能具有很好的应用前景。Beneficial effect: Compared with the prior art, the (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber of the present invention has the outstanding advantage that: the present invention uses cheap and easy-to-obtain β - pinene as raw material, through selective oxidation to obtain nopinone with a bicyclic structure similar to camphor, and then carry out aldol condensation reaction with aromatic aldehydes of different structures to synthesize ultraviolet absorbers, with simple synthetic route, simple and economical operation , high yield, less pollution and other advantages, it overcomes the disadvantages of long synthetic route and high price of camphor. The synthesized ultraviolet absorber has the advantages of good ultraviolet absorption effect, wide ultraviolet absorption spectrum range and the like, and has a good application prospect in absorbing ultraviolet rays.
附图说明 Description of drawings
图1是(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物的光降解测定结果图;Fig. 1 is (1R, 5R)-(-)-3-aryl methylene nopinone derivative photodegradation assay result figure;
图2是(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物的吸光度值变化结果图。Fig. 2 is a diagram showing the results of changes in absorbance of (1R, 5R)-(-)-3-arylmethylene nopinone derivatives.
具体实施方式 Detailed ways
下面结合具体实施例对本发明做进一步的解释。The present invention will be further explained below in conjunction with specific examples.
实施例1:诺蒎酮的制备Embodiment 1: the preparation of nopinone
诺蒎酮的制备方法,可以参照文献[左旋β-蒎烯选择性氧化合成右旋诺蒎酮的研究,南京林业大学学报:自然科学版,2010,34(2),89-94]中公开的方法进行。也可以使用以下方法:The preparation method of nopinone can be disclosed in the literature [Research on the Selective Oxidation of L-β-pinene to D-Nopinene, Journal of Nanjing Forestry University: Natural Science Edition, 2010, 34 (2), 89-94] method is carried out. You can also use the following methods:
在配有搅拌器、温度计、恒压加料漏斗和回流冷凝管的100mL四口烧瓶中加入丙酮、硫酸和β-蒎烯,冰浴冷却至15℃左右,分批加入充分碾细的KMnO4,在1~1.5h内加完。移去冰浴,在室温下继续反应5~6h。反应结束后,用砂芯漏斗过滤除去MnO2,再用丙酮洗涤固体残渣。用旋转浓缩仪回收丙酮,剩余物中加入环己烷,用饱和食盐水洗涤至中性后,用无水Na2SO4干燥有机层,常压下蒸去环己烷后,再减压精馏,收集100~102℃/2.7kPa馏分,得到无色油状液体的中间产物诺蒎酮,纯度为95.3%,比旋光度为 Add acetone, sulfuric acid and β-pinene into a 100mL four-neck flask equipped with a stirrer, thermometer, constant pressure addition funnel and reflux condenser, cool in an ice bath to about 15°C, add fully ground KMnO 4 in batches, Added within 1 ~ 1.5h. The ice bath was removed, and the reaction was continued at room temperature for 5-6 h. After the reaction was finished, MnO 2 was removed by filtration with a sand core funnel, and the solid residue was washed with acetone. Use a rotary concentrator to recover acetone, add cyclohexane to the residue, wash with saturated brine until neutral, dry the organic layer with anhydrous Na 2 SO 4 , distill off cyclohexane under normal pressure, and then purify under reduced pressure. Distillation, collect 100~102 ℃/2.7kPa distillate, obtain the intermediate product nopinone of colorless oily liquid, purity is 95.3%, specific rotation is
实施例2:(1R,5R)-(-)-3-芳亚甲基诺蒎酮类紫外线吸收剂的制备Embodiment 2: Preparation of (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber
在碱催化作用下,取实施例1制备的(1R,5S)-(+)-诺蒎酮,分别与对羟基苯甲醛、香兰素、邻香兰素、对氯苯甲醛、糠醛进行羟醛缩合反应,进一步脱水后得到(1R,5R)-(-)-3-(4′-羟基亚苄基)诺蒎酮(1)、(1R,5R)-(-)-3-(4′-羟基-3′-甲氧基亚苄基)诺蒎酮(2)、(1R,5R)-(-)-3-(2′-羟基-3′-甲氧基亚苄基)诺蒎酮(3)、(1R,5R)-(-)-3-(4′-氯亚苄基)诺蒎酮(4)、(1R,5R)-(-)-3-(呋喃-2′-基亚甲基)诺蒎酮(5)。Under alkali catalysis, take (1R, 5S)-(+)-nopinone prepared in Example 1, and carry out hydroxylation with p-hydroxybenzaldehyde, vanillin, o-vanillin, p-chlorobenzaldehyde and furfural respectively. Aldehyde condensation reaction, after further dehydration, (1R, 5R)-(-)-3-(4'-hydroxybenzylidene) nopinone (1), (1R, 5R)-(-)-3-(4 '-Hydroxy-3'-methoxybenzylidene)nopinone (2), (1R,5R)-(-)-3-(2'-hydroxy-3'-methoxybenzylidene)nopine Pinone (3), (1R,5R)-(-)-3-(4′-chlorobenzylidene)nopineone (4), (1R,5R)-(-)-3-(furan-2 '-ylmethylene)nopinone (5).
(1R,5R)-(-)-3-(4′-羟基亚苄基)诺蒎酮(1)的制备:Preparation of (1R, 5R)-(-)-3-(4'-hydroxybenzylidene)nopinone (1):
将1.38g(0.01mol)诺蒎酮、浓度为10%的叔丁醇钾叔丁醇溶液30ml和1.83g(0.015mol)对羟基苯甲醛加入配有搅拌器、温度计和回流冷凝器的100mL三口烧瓶中,氮气保护下回流反应7~8h至诺蒎酮转化率达95%以上(GC跟踪检测)。反应液经乙酸乙酯萃取3次,合并的有机相用水和饱和食盐水洗至中性,经无水Na2SO4干燥、过滤、浓缩后得到黄色固体粗产物,再用丙酮溶解,回流至溶液透明、经过滤后滤液放置数天进行重结晶,得到无色透明的(1R,5R)-(-)-3-(4-羟基亚苄基)诺蒎酮晶体,得率为38.8%,GC纯度97.4%;m.p.199.6~200.6℃;(c=0.6,CCl3);FT-IR(KBr)n(cm-1):3378(nO-H),2962~2911(nC-H),1669(nC=O),1607~1469(苯环,nasC=C),987~647(单取代苯环,tC-H);EI-MS m/z(%):242(M+,100),227(M+-15,31),199(227-C2H4,42),186(22),171(47),132(56),107(54),83(35),55(53),41(34)。Add 1.38g (0.01mol) nopinone, 30ml of potassium tert-butoxide tert-butanol solution with a concentration of 10% and 1.83g (0.015mol) p-hydroxybenzaldehyde into a 100mL three port equipped with stirrer, thermometer and reflux condenser In the flask, reflux under nitrogen protection for 7-8 hours until the conversion rate of nopinone reaches more than 95% (GC tracking detection). The reaction solution was extracted 3 times with ethyl acetate, the combined organic phase was washed with water and saturated brine until neutral, dried over anhydrous Na 2 SO 4 , filtered, and concentrated to obtain a yellow solid crude product, which was then dissolved in acetone and refluxed to the solution Transparent, after filtration, the filtrate was placed for several days for recrystallization, and a colorless and transparent (1R, 5R)-(-)-3-(4-hydroxybenzylidene)nopineone crystal was obtained, with a yield of 38.8%, GC Purity 97.4%; mp199.6~200.6℃; (c=0.6, CCl 3 ); FT-IR(KBr)n(cm -1 ): 3378(n OH ), 2962~2911(n CH ), 1669(n C=O ), 1607~1469(benzene , n asC=C ), 987~647 (monosubstituted benzene ring, t CH ); EI-MS m/z (%): 242 (M + , 100), 227 (M + -15, 31), 199 ( 227- C2H4 , 42 ), 186(22), 171(47), 132(56), 107(54), 83(35), 55(53), 41(34).
(1R,5R)-(-)-3-(4′-羟基-3′-甲氧基亚苄基)诺蒎酮(2)的制备:Preparation of (1R, 5R)-(-)-3-(4'-hydroxy-3'-methoxybenzylidene)nopinone (2):
将1.38g(0.01mol)诺蒎酮、浓度为10%的叔丁醇钾甲苯溶液30ml和1.824g(0.012mol)香兰素(3-甲氧基-4-羟基苯甲醛)加入配有搅拌器、温度计和回流冷凝器的100mL三口烧瓶中,氮气保护下回流反应10~12h,诺蒎酮转化率达70~80%,其中有约10~15%的副产物和70~75%的主产物。反应液经乙酸乙酯萃取3次,合并的有机相用水和饱和食盐水洗至中性,经无水Na2SO4干燥、过滤、浓缩后得到黄色固体粗产物,再用丙酮溶解,加少许乙醇并回流至溶液透明、经过滤后滤液放置数天进行重结晶,得到无色透明的(1R,5R)-(-)-3-(4-羟基-3-甲氧基亚苄基)诺蒎酮晶体,得率为19.2%,GC纯度95.3%,m.p.173.5~1742℃,(c=0.32,CCl3)。FT-IR(KBr)v(cm-1):3238(vO-H),2966~2901(vC-H),1674(vC=O),1593~1440(苯环,vasC=C),1307~1130(vO-CH3),856~619(τC-H);EI-MS m/z(%):272(M+,100),257(19),229(18),203(30),162(26),137(24),115(21),91(20),83(16),55(33),41(19)。Add 1.38g (0.01mol) nopinone, 30ml of 10% potassium tert-butoxide toluene solution and 1.824g (0.012mol) vanillin (3-methoxy-4-hydroxybenzaldehyde) with stirring In a 100mL three-necked flask with a thermometer, a thermometer and a reflux condenser, the reflux reaction was carried out under nitrogen protection for 10-12 hours, and the conversion rate of nopinone reached 70-80%, and there were about 10-15% of by-products and 70-75% of the main product. The reaction solution was extracted three times with ethyl acetate, and the combined organic phase was washed with water and saturated brine until neutral, dried over anhydrous Na 2 SO 4 , filtered, and concentrated to obtain a yellow solid crude product, which was dissolved in acetone and added a little ethanol And reflux until the solution is transparent, and after filtration, the filtrate is placed for several days for recrystallization to obtain colorless and transparent (1R, 5R)-(-)-3-(4-hydroxyl-3-methoxybenzylidene)nopine Ketone crystals, yield 19.2%, GC purity 95.3%, mp173.5~1742℃, (c=0.32, CCl3). FT-IR (KBr) v (cm -1 ): 3238 (v OH ), 2966~2901 (v CH ), 1674 (v C=O ), 1593~1440 (benzene ring, v asC=C ), 1307~ 1130 (v O-CH3 ), 856~619 (τ CH ); EI-MS m/z (%): 272 (M + , 100), 257 (19), 229 (18), 203 (30), 162 (26), 137(24), 115(21), 91(20), 83(16), 55(33), 41(19).
(1R,5R)-(-)-3-(2′-羟基-3′-甲氧基亚苄基)诺蒎酮(3)的制备:Preparation of (1R, 5R)-(-)-3-(2'-hydroxy-3'-methoxybenzylidene)nopinone (3):
将2.76g(0.02mol)诺蒎酮、浓度为20%的叔丁醇钾甲苯溶液30ml和3.65g(0.024mol)邻香兰素(3-甲氧基-2-羟基苯甲醛)加入配有搅拌器、温度计和回流冷凝器的100mL三口烧瓶中,氮气保护下回流反应20~22h,诺蒎酮转化率为50%。反应液经甲苯萃取3次,合并的有机相用水和饱和食盐水洗至中性,经无水Na2SO4干燥、过滤、浓缩后得到黄色固体粗产物,再用丙酮溶解,加少许乙醇并回流至溶液透明、经过滤后滤液放置数天进行重结晶,得到无色透明的(1R,5R)-(-)-3-(2-羟基-3-甲氧基亚苄基)诺蒎酮晶体,得率为47.1%,GC纯度96.8%,m.p.195.2~195.6℃,(c=0.24,CCl3);FT-IR(KBr)v(cm-1):3246(vO-H),2959~2935(vC-H),1673(vC=O),1597~1440(苯环,vasC=C),1301~1201(vO-CH3),795~726(τC-H);EI-MS m/z(%):272(M+,30),231(100),213(14),197(13),161(24),137(21),128(12),115(21),91(21),55(33),41(19)。Add 2.76g (0.02mol) nopinone, 20% potassium tert-butoxide toluene solution 30ml and 3.65g (0.024mol) o-vanillin (3-methoxy-2-hydroxybenzaldehyde) In a 100mL three-necked flask with a stirrer, a thermometer and a reflux condenser, the reflux reaction was carried out under nitrogen protection for 20-22 hours, and the conversion rate of nopinone was 50%. The reaction solution was extracted 3 times with toluene, the combined organic phase was washed with water and saturated brine until neutral, dried over anhydrous Na 2 SO 4 , filtered, and concentrated to obtain a yellow solid crude product, which was dissolved in acetone, added a little ethanol and refluxed After the solution is transparent, after filtration, the filtrate is left for several days for recrystallization, and a colorless and transparent crystal of (1R, 5R)-(-)-3-(2-hydroxy-3-methoxybenzylidene)nopinone is obtained , yield 47.1%, GC purity 96.8%, mp195.2~195.6℃, (c=0.24, CCl 3 ); FT-IR(KBr)v(cm -1 ): 3246(v OH ), 2959~2935(v CH ), 1673(v C=O ), 1597~1440(benzene ring , v asC=C ), 1301~1201(v O-CH3 ), 795~726(τ CH ); EI-MS m/z(%): 272(M + , 30), 231(100), 213( 14), 197(13), 161(24), 137(21), 128(12), 115(21), 91(21), 55(33), 41(19).
(1R,5R)-(-)-3-(4′-氯亚苄基)诺蒎酮(4)的制备:Preparation of (1R, 5R)-(-)-3-(4'-chlorobenzylidene)nopinone (4):
将1.38g(0.01mol)诺蒎酮、浓度为10%的甲醇钠叔丁醇溶液30ml和1.68g(0.012mol)对氯苯甲醛加入配有搅拌器、温度计和回流冷凝器的100mL三口烧瓶中,氮气保护下回流反应5~8h,诺蒎酮转化率达100%。反应液加入饱和食盐水并用乙酸乙酯萃取3次,合并的有机相用水和饱和食盐水洗至中性,经无水Na2SO4干燥、过滤、浓缩后得到黄色固体粗产物,再用丙酮溶解,加少许乙醇并回流至溶液透明、经过滤后滤液放置数天进行重结晶,得到黄色透明的(1R,5R)-(-)-3-(4-氯亚苄基)诺蒎酮晶体,得率为85.5%,GC纯度97.8%,m.p.109.7~110.7℃,(c=0.31,CCl3);FT-IR(KBr)v(cm-1):2984~2874(vC-H),1686(vC=O),1686~1407(苯环,vasC=C),979~686(苯环对取代);EI-MSm/z(%):260(M+,97),245(54),217(54),204(21),189(39),165(31),150(48),141(47),125(48),115(100),83(78),55(89)。Add 1.38g (0.01mol) nopinone, 30ml of 10% sodium methoxide tert-butanol solution and 1.68g (0.012mol) p-chlorobenzaldehyde into a 100mL three-necked flask equipped with a stirrer, thermometer and reflux condenser , reflux reaction under the protection of nitrogen for 5-8 hours, and the conversion rate of nopinone reached 100%. The reaction solution was added with saturated brine and extracted three times with ethyl acetate, the combined organic phase was washed with water and saturated brine until neutral, dried over anhydrous Na 2 SO 4 , filtered and concentrated to obtain a yellow solid crude product, which was then dissolved in acetone , add a little ethanol and reflux until the solution is transparent, after filtration, the filtrate is placed for several days for recrystallization, and yellow transparent (1R, 5R)-(-)-3-(4-chlorobenzylidene)nopineone crystals are obtained. Yield is 85.5%, GC purity is 97.8%, mp109.7~110.7℃, (c=0.31, CCl 3 ); FT-IR(KBr)v(cm -1 ): 2984~2874 (v CH ), 1686(v C=O ), 1686~1407 (benzene ring, v asC=C ) , 979~686 (para-substituted benzene ring); EI-MSm/z(%): 260(M + , 97), 245(54), 217(54), 204(21), 189(39), 165( 31), 150(48), 141(47), 125(48), 115(100), 83(78), 55(89).
(1R,5R)-(-)-3-(呋喃-2′-基亚甲基)诺蒎酮(5)的制备:Preparation of (1R, 5R)-(-)-3-(furan-2'-ylmethylene)nopinone (5):
将1.38g(0.01mol)诺蒎酮、浓度为10%的NaOH乙醇溶液30ml和1152g(0.012mol)糠醛加入配有搅拌器、温度计和回流冷凝器的100mL三口烧瓶中,氮气保护下回流反应4~4.5h,诺蒎酮转化率达93.6%。反应液加入饱和食盐水并用乙酸乙酯萃取3次,合并的有机相用水和饱和食盐水洗至中性,经无水Na2SO4干燥、过滤、浓缩后得到黄色固体粗产物,经过硅胶柱色谱分离后[V石油醚∶V乙酸乙酯=6∶1],得到黄色液体(1R,5R)-(-)-3-(呋喃-2-基亚甲基)诺蒎酮,得率为85.5%,GC纯度97.1%,(c=0.5,CCl3);FT-IR(KBr)v(cm-1):3435(v=C-H),2935(vC-H),1691(vC=O),1610~1548(呋喃环,vC=C),1297~1195(vC-O-C),744(δc=c面外弯曲振动);EI-MS m/z(%):216(M+,86),201(27),173(100),145(35),131(15),115(21),106(37),91(31),78(24),65(14),55(38),41(16),39(18)。1.38g (0.01mol) nopinone, 10% NaOH ethanol solution 30ml and 1152g (0.012mol) furfural were added in the 100mL three-necked flask equipped with stirrer, thermometer and reflux condenser, and reflux reaction under nitrogen protection 4 After ~4.5h, the conversion rate of nopinone reached 93.6%. The reaction solution was added with saturated brine and extracted 3 times with ethyl acetate, the combined organic phase was washed with water and saturated brine until neutral, dried over anhydrous Na 2 SO 4 , filtered and concentrated to obtain a yellow solid crude product, which was subjected to silica gel column chromatography After separation [V petroleum ether : V ethyl acetate = 6:1], a yellow liquid (1R, 5R)-(-)-3-(furan-2-ylmethylene)nopinone was obtained with a yield of 85.5 %, GC purity 97.1%, (c=0.5, CCl 3 ); FT-IR(KBr)v(cm -1 ): 3435(v= CH ), 2935(v CH ), 1691(v C=O ), 1610~1548(furan ring, v C=C ), 1297~1195 (v COC ), 744 (δ c=c out-of-plane bending vibration); EI-MS m/z(%): 216(M + , 86), 201(27), 173 (100), 145(35), 131(15), 115(21), 106(37), 91(31), 78(24), 65(14), 55(38), 41(16), 39 (18).
比较制备的5种(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物的物理性质,结果如表1所示。The physical properties of five kinds of (1R, 5R)-(-)-3-arylene nopinone derivatives prepared were compared, and the results are shown in Table 1.
表1(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物的物理性质The physical properties of table 1 (1R, 5R)-(-)-3-aryl methylene nopinone derivatives
从表1可知:合成所得5种(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物均具有较高的光学活性,但芳基结构不同及相同芳基所带不同取代基所得产物的旋光性各有不同,其中(1R,5R)-(-)-3-(2-羟基-3-甲氧基亚苄基)诺蒎酮的比旋光度最高,其次是(1R,5R)-(-)-3-(4-羟基亚苄基)诺蒎酮,而(1R,5R)-(-)-3-(呋喃-2-基亚甲基)诺蒎酮最小。It can be seen from Table 1 that the five (1R, 5R)-(-)-3-arylmethylene nopinone derivatives obtained by synthesis all have high optical activity, but the aryl structure is different and the same aryl group has different The optical activity of the products obtained by the substituents is different, and the specific optical rotation of (1R, 5R)-(-)-3-(2-hydroxyl-3-methoxybenzylidene)nopinone is the highest, followed by ( 1R,5R)-(-)-3-(4-hydroxybenzylidene)nopinone, while (1R,5R)-(-)-3-(furan-2-ylmethylene)nopinone is the least .
实施例3(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物的吸光能力测定The light-absorbing capacity of embodiment 3 (1R, 5R)-(-)-3-aryl methylene nopinone derivatives is measured
将实施例2所合成的5种化合物溶于55%乙醇中,配置成质量分数约为0.0015%左右的溶液,在200~700nm范围内进行全紫外扫描,测定其吸光度范围和最大吸收波长。并根据下式计算出各化合物摩尔吸光系数ε,结果如表2所示。The 5 compounds synthesized in Example 2 were dissolved in 55% ethanol to form a solution with a mass fraction of about 0.0015%, and full-ultraviolet scanning was performed in the range of 200-700nm to measure the absorbance range and maximum absorption wavelength. The molar absorptivity ε of each compound was calculated according to the following formula, and the results are shown in Table 2.
ε=A/CLε=A/CL
A-吸光度A-absorbance
ε-摩尔吸光系数,L/mol.cmε-molar absorptivity, L/mol.cm
C-样品的浓度,mol/L,C-sample concentration, mol/L,
L-光路的长度,cmL-length of optical path, cm
表2(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物的紫外吸收范围及最大吸收波长Table 2 (1R, 5R)-(-)-3-aryl methylene nopinone derivatives UV absorption range and maximum absorption wavelength
由表2可知:化合物1-5均具有较强的紫外吸收。化合物3和5的紫外吸收范围分别为280~390nm和270~370nm,最大吸收波长λmax和吸光值分别为306nm、24780L/mol·cm和322.5nm、22290L/mol·cm,具备了作为UV-A型紫外吸收剂的条件;化合物2则具有最宽的紫外吸收范围,并且最大吸收波长λmax达335nm,具有同时能吸收UV-A和UV-B的功能;从摩尔吸光系数可知,各化合物对吸收紫外线的能力顺序为:(4)>(1)>(3)>(2)>(5)。It can be seen from Table 2 that compounds 1-5 all have strong UV absorption. The ultraviolet absorption ranges of
实施例4(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物的光降解测定Photodegradation Determination of Embodiment 4 (1R, 5R)-(-)-3-aryl methylene nopinone derivatives
各取实施例3所配的5种溶液50ml分别注入3只相同规格的具塞锥形瓶中,1只避光保存,1只置于室内,1只置于太阳光下。以同样乙醇质量分数的水溶液为参比,每天测定其在最大吸收波长处的吸光度,计算各化合物在不同条件下的降解率,比较各紫外吸收剂的光稳定性。50 ml of the 5 solutions prepared in Example 3 were respectively injected into 3 conical flasks with stoppers of the same specification, 1 was kept in the dark, 1 was placed indoors, and 1 was placed under sunlight. Taking the aqueous solution with the same mass fraction of ethanol as a reference, measure its absorbance at the maximum absorption wavelength every day, calculate the degradation rate of each compound under different conditions, and compare the photostability of each ultraviolet absorber.
试验结果如图1所示,实施例2所制备的5种(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物在光照下的其吸光度的变化各有不同,化合物1和2的吸光度在前两天的变化比较明显,第二天与第一天相比,吸光度分别下降了6.2%和7.0%,而在二天以后它们的吸光度基本不发生变化,均在0.35%以内;化合物3和4的吸光度在前两天变化较小,分别为为1.7%和1.0%;而化合物5的吸光度几乎没有变化,第二天比第一天仅下降0.1%。所有5种化合物在第三天以后的吸光度几乎都不发生变化。由此表明:化合物的稳定性顺序为5>4>3>1>2,总体看来,这5种化合物的均具有较好的光稳定性。Test result as shown in Figure 1, the change of its absorbance of 5 kinds of (1R, 5R)-(-)-3-aryl methylene nopinone derivatives prepared in
以同样的方法,对所合成的5种芳亚甲基诺蒎酮衍生物在室内和避光条件下的吸光度变化也进行测定,与直接太阳光照射相比,在室内和避光条件下,这些化合物的光降解现象减弱,光稳定性增强。在室内和避光条件下,紫外吸收剂的光降解趋势减慢,且紫外吸收剂对甲基苯甲醛还表现出吸光度有所增加的趋势。可见在室内和避光条件下,其光稳定性更好。对比室内和避光条件下的光稳定性,可知,在避光条件下,光稳定性更好。In the same way, the absorbance changes of the synthesized 5 kinds of arylmethylene nopinone derivatives were also measured indoors and under light-shielding conditions. Compared with direct sunlight irradiation, under indoor and light-shielding conditions, The photodegradation phenomenon of these compounds is weakened and the photostability is enhanced. Under indoor and dark conditions, the photodegradation tendency of the UV absorber slowed down, and the absorbance of the UV absorber p-tolualdehyde also showed a tendency to increase. It can be seen that its photostability is better indoors and under dark conditions. Comparing the photostability under indoor and dark conditions, it can be seen that the photostability is better under dark conditions.
将合成的5种(1R,5R)-(-)-3-芳亚甲基诺蒎酮衍生物,按等质量比进行复配,并用55%的乙醇作溶剂配成溶液,在200~400nm条件下进行全扫描,测定其紫外吸收范围,确定其最大吸收波长;将复配物分别放置在光照、室内和避光等三种条件下,每天测定其在最大吸收波长下得吸光值的变化,从而测定复配物的光稳定性。The five synthetic (1R, 5R)-(-)-3-arylmethylene nopinone derivatives were compounded in equal mass ratios, and 55% ethanol was used as a solvent to form a solution, and at 200-400nm Carry out a full scan under the same conditions, measure its ultraviolet absorption range, and determine its maximum absorption wavelength; place the compound under three conditions of light, indoor and dark, and measure the change of its absorbance value at the maximum absorption wavelength every day , so as to determine the photostability of the compound.
将5种紫外吸收剂按照均等的比例配置成溶剂,在200~400nm条件下进行全扫描,发现该复配溶剂的紫外吸收波长范围变的更加广泛,且在不同的波长位置,其紫外吸收强度各不相同。单个的紫外吸收剂的最大吸收峰在289.5~322.5之间,经过复配以后,紫外吸收全扫描显示,其最强紫外吸收峰在307nm处,所以选用307nm处的光稳定性来考察复配物的光稳定性变化特征。Five kinds of UV absorbers were formulated into solvents in equal proportions, and a full scan was performed under the condition of 200-400nm. It was found that the UV absorption wavelength range of the compound solvent became wider, and at different wavelength positions, its UV absorption intensity vary. The maximum absorption peak of a single UV absorber is between 289.5 and 322.5. After compounding, the full scan of UV absorption shows that its strongest UV absorption peak is at 307nm, so the photostability at 307nm is selected to investigate the compound The characteristics of photostability changes.
将配置好的复配溶液,按照相同的方法,分别放置在光照,室内,避光条件下,每天检测其吸光度值的变化,结果如图2所示,不同条件下的复配物的吸光度从第三天和第四天开始,下降幅度逐级减小,开始趋于稳定。因此考察复配物的光稳定性从第四天开始比较。选取后四天的吸光度的变化数值,计算其下降率,比较复配物在不同条件下的光稳定性。由实验数据可得,在三种条件下,复配物的光稳定性比单个产物的稳定性要高,且仍然满足在光照下降解速度最快,密闭环境中,降解速度最慢,稳定性最好。Place the prepared compound solution in the same way under light, indoor, and light-proof conditions, and detect the change of its absorbance value every day. The results are shown in Figure 2. The absorbance of the compound under different conditions ranges from From the third day to the fourth day, the decline gradually decreased and began to stabilize. Therefore, the comparison of photostability of the compound was investigated from the fourth day. Select the change value of the absorbance in the last four days, calculate its decline rate, and compare the photostability of the compound under different conditions. According to the experimental data, under the three conditions, the photostability of the compound is higher than that of a single product, and it still satisfies the fastest degradation rate under light, the slowest degradation rate in a closed environment, and the stability most.
综上所述,对于不同的取代基,该系列产物均具有很广泛的紫外吸收范围,且消光系数高,稳定性好,水醇溶液的降解率较低,具有很好的紫外光吸收曲线。且该系列产物在复配条件下,紫外吸收范围更广,稳定性更佳。同时,作为紫外吸收剂的物质,最宜避光保存。To sum up, for different substituents, this series of products have a wide range of ultraviolet absorption, high extinction coefficient, good stability, low degradation rate of hydroalcoholic solution, and good ultraviolet absorption curve. And this series of products have a wider range of UV absorption and better stability under compounding conditions. At the same time, as a UV absorber, it is best to keep it away from light.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110261873.4A CN102391088B (en) | 2011-09-06 | 2011-09-06 | (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110261873.4A CN102391088B (en) | 2011-09-06 | 2011-09-06 | (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102391088A CN102391088A (en) | 2012-03-28 |
CN102391088B true CN102391088B (en) | 2014-03-05 |
Family
ID=45858498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110261873.4A Expired - Fee Related CN102391088B (en) | 2011-09-06 | 2011-09-06 | (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102391088B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103086852B (en) * | 2013-02-21 | 2015-10-21 | 南京林业大学 | One prepares the novel method of 2,3-pinane diketone |
CN103980217B (en) * | 2014-05-26 | 2015-12-30 | 南京林业大学 | One class pinane isoxazole compounds and synthetic method thereof and application |
CN105503561B (en) * | 2015-12-24 | 2018-01-19 | 南京林业大学 | A kind of acid-base indicator and its synthetic method and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178852A (en) * | 1989-03-31 | 1993-01-12 | L'oreal | Cosmetic and pharmaceutical compositions containing lipophilic derivatives of benzylidenecamphor and new lipophilic derivatives of benzylidenecamphor |
US5730960A (en) * | 1994-07-23 | 1998-03-24 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Benzylidenenorcamphor derivatives |
-
2011
- 2011-09-06 CN CN201110261873.4A patent/CN102391088B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178852A (en) * | 1989-03-31 | 1993-01-12 | L'oreal | Cosmetic and pharmaceutical compositions containing lipophilic derivatives of benzylidenecamphor and new lipophilic derivatives of benzylidenecamphor |
US5730960A (en) * | 1994-07-23 | 1998-03-24 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Benzylidenenorcamphor derivatives |
Non-Patent Citations (2)
Title |
---|
刘兵等.左旋β-蒎烯选择性氧化合成右旋诺蒎酮的研究.《南京林业大学学报(自然科学版)》.2010,第34卷(第2期),第89-94页. |
左旋β-蒎烯选择性氧化合成右旋诺蒎酮的研究;刘兵等;《南京林业大学学报(自然科学版)》;20100331;第34卷(第2期);第89-94页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102391088A (en) | 2012-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3637055B2 (en) | Use of benzimidazole derivatives as light protection filters | |
US10799441B2 (en) | Skin treatments containing pyrroloquinoline quinone (PQQ) esters and methods of preparation and use thereof | |
CN102391088B (en) | (1R, 5R)-(-)-3-arylmethylene nopinone ultraviolet absorber and preparation method thereof | |
JPH11507941A (en) | Chemical compound and method for producing the same | |
KR101148978B1 (en) | Cosmetic Composition for Blocking Ultraviolet-A Comprising Extract of Gracilariopsis Chorda | |
CN111269124B (en) | A kind of reactive ultraviolet absorber and its preparation method and application | |
TW202241842A (en) | Process of manufacturing 2-(4’-diethylamino-2’-hydroxybenzoyl)benzoic acid hexyl ester | |
CN113692403B (en) | Compounds having excited state intramolecular proton transfer (ESIPT) properties for use in treating and/or preventing sunburn and/or preventing U.V. damage | |
CN110483331B (en) | Benzophenone Schiff base ultraviolet absorber and preparation method thereof | |
Joo et al. | UV absorbent, marmesin, from the bark of Thanakha, Hesperethusa crenulata L. | |
CN104367486A (en) | Application of fraxinol glucosides in uvioresistant cosmetics | |
Starkowsky et al. | Ammajin, a new constituent of Ammi majus (L.) | |
KR101684671B1 (en) | A novel quinoxaline compound for ultraviolet absorbers | |
Xu et al. | Synthesis and Ultraviolet Absorption Characteristics of Chiral 3-arylidenenopinones from β-pinene | |
CN102826983A (en) | 4-arylmethylidene-2-hydroxy-3-pinone derivative as well as preparation method and application thereof | |
JP5916348B2 (en) | Novel serotonin compound, tyrosinase inhibitor, and discoloration inhibitor | |
JPH023638A (en) | 1,2-bis(dimethylaminocinnamoyloxy)propane derivative and ultraviolet light absorber containing the same derivative | |
RUI et al. | Synthesis and ultraviolet absorption characteristics of 7-arylidene-isolongifolanene | |
JP2002053527A (en) | 5,5-Diaryl-2,4-pentadienoate compound and ultraviolet absorber containing the compound as active ingredient | |
TWM480924U (en) | Sunscreen container structure | |
WO2025022833A1 (en) | Ultraviolet absorber, antioxidant, anti-glycation agent, external preparation for skin, cosmetic, method for producing compound, and compound | |
JPH02243647A (en) | 4-hydroxydibenzoylmethane derivative, uv light absorbent and cosmetic | |
KR20230012009A (en) | Purification method of 2-(4'-diethylamino-2'-hydroxybenzoyl)benzoic acid hexyl ester | |
JPH02134341A (en) | 2-benzoyl-1-tetralon derivative | |
KR101601777B1 (en) | Cornus walteri leaf extract for improving the photo-stability of sunscreen agent and cosmetic composition for UV screening containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140305 Termination date: 20150906 |
|
EXPY | Termination of patent right or utility model |